Volume 71, Issue 6, Pages (March 2007)

Slides:

Advertisements

Similar presentations

Kamyar Kalantar-Zadeh Kidney International

Advertisements

The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent.

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Severity of primary MPGN, rather than MPGN type, determines renal survival and post- transplantation recurrence risk M.A. Little, P. Dupont, E. Campbell,

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Linear and logistic regression analysis

Volume 83, Issue 3, Pages (March 2013)

Volume 58, Issue 4, Pages (October 2000)

C-reactive protein and dialysis access

Naïve and central memory T-cell lymphopenia in end-stage renal disease

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Volume 69, Issue 5, Pages (March 2006)

C-reactive protein and dialysis access

Volume 54, Issue 2, Pages (August 1998)

Rutger J.H. Maas, Jack F.M. Wetzels, Jeroen K.J. Deegens

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Kamyar Kalantar-Zadeh Kidney International

Volume 94, Issue 5, Pages (November 2018)

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 72, Issue 9, Pages (November 2007)

Volume 73, Issue 5, Pages (March 2008)

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Volume 70, Issue 11, Pages (December 2006)

Benefits of preserving residual renal function in peritoneal dialysis

Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension A. Davenport, C. Cox, R. Thuraisingham Kidney.

Clinical relevance of FGF-23 in chronic kidney disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Blood pressure targets in hemodialysis patients

Volume 69, Issue 10, Pages (May 2006)

Fructose intake as a risk factor for kidney stone disease

Combined Use of the Novel Biomarkers High-Sensitivity Troponin T and ST2 for Heart Failure Risk Stratification vs Conventional Assessment Josep Lupón,

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function S.L.S. Fan, T. Pile, S. Punzalan, M.J.

Volume 74, Issue 5, Pages (September 2008)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Volume 71, Issue 12, Pages (June 2007)

Volume 77, Issue 12, Pages (June 2010)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1 Robert N. Foley, Charles A. Herzog, Allan J.

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Organ transplantation goes to the movies

Low triiodothyronine and survival in end-stage renal disease

Volume 72, Issue 2, Pages (July 2007)

Volume 63, Issue 2, Pages (February 2003)

Volume 69, Issue 1, Pages (January 2006)

Volume 72, Issue 2, Pages (July 2007)

Volume 75, Issue 4, Pages (February 2009)

Treatment of the primary hyperoxalurias: A new chapter

Volume 70, Issue 7, Pages (October 2006)

Volume 57, Issue 3, Pages (March 2000)

Fetuin-A is not associated with mortality in chronic kidney disease

Volume 87, Issue 3, Pages (March 2015)

Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease A.R. Chade, D. Brosh, S.T.

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients M.R. Marshall, B.G. Byrne, P.G. Kerr,

Volume 63, Issue 5, Pages (May 2003)

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Optimization of pre-ESRD care: The key to improved dialysis outcomes

A. Lauschke, U.K.M. Teichgräber, U. Frei, K.-U. Eckardt

Characteristics of sudden death in hemodialysis patients

P.A. McFarlane, A.M. Bayoumi, A. Pierratos, D.A. Redelmeier

Severity of primary MPGN, rather than MPGN type, determines renal survival and post- transplantation recurrence risk M.A. Little, P. Dupont, E. Campbell,

Presentation transcript:

Volume 71, Issue 6, Pages 548-554 (March 2007) N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis L.H. Madsen, S. Ladefoged, P. Corell, M. Schou, P.R. Hildebrandt, D. Atar Kidney International Volume 71, Issue 6, Pages 548-554 (March 2007) DOI: 10.1038/sj.ki.5002087 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Pre- and post-dialysis concentrations of NT-proBNP (4079 vs 2759pg/ml; median values, P<0.001). Kidney International 2007 71, 548-554DOI: (10.1038/sj.ki.5002087) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Serum concentrations of NT-proBNP graphically shown for variables (tertiles) significantly affecting levels in a multivariate linear regression analysis (LVEF in modified tertiles). Significance between groups is indicated by * and **P<0.05. Kidney International 2007 71, 548-554DOI: (10.1038/sj.ki.5002087) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Serum concentrations of NT-proBNP graphically shown for volume overload (quartiles). Kidney International 2007 71, 548-554DOI: (10.1038/sj.ki.5002087) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 Kaplan–Meier survival curves according to concentrations of NT-proBNP above and below median values (pre- and post-dialysis). Kidney International 2007 71, 548-554DOI: (10.1038/sj.ki.5002087) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 Receiver operator characteristics curve for pre- and post-dialysis concentrations of NT-proBNP with sensitivity, specificity, and hazard ratio at different cutoff levels of predialysis concentrations of NT-proBNP. Areas under the receiver operator characteristics curve for pre- and post-dialysis values are 0.718 and 0.729, respectively. *Median value. Kidney International 2007 71, 548-554DOI: (10.1038/sj.ki.5002087) Copyright © 2007 International Society of Nephrology Terms and Conditions